Global office locator

Join us tomorrow at the SCDM India Single Day Event in Hyderabad, where ICON's Gangotri Boni will serve as Event Co Chair and lead the session, 'Transforming information into insights'. Discover how data can be transfo...

To mark International Yoga Day, colleagues across India took part in Desktop Yoga Week, a wellbeing initiative designed to encourage simple moments of movement and mindfulness during the working day. More than 850 colle...

Last week, we officially relocated our Guangzhou office, marking an exciting milestone for our growing team in China. The new workspace offers upgraded facilities, a modern working environment, improved accessibility, a...

Join us at this year's SCDM India Single Day Event on 11 July in Hyderabad, where ICON's Gangotri Boni will be serving as Event Co Chair and chairing the session, 'Transforming information into insights'. Discover how ...

We are proud to be recognised once again by TIME as one of the World’s Most Sustainable Companies 2026. This marks the second consecutive year ICON has received this prestigious accolade, reflecting our continued commit...

Biosimilar development is entering a more complex and competitive era. From advanced biologic modalities to evolving regulatory expectations, success now depends on building flexibility and rigour into development strate...

Critical care trials present unique challenges—from narrow enrolment windows and surrogate consent to rapidly changing patient conditions—requiring thoughtful design aligned with the realities of ICU care. Learn more: h...

Colleagues in Chennai recently came together for the inaugural Q2 Fun Event, organised by the India Employee Recreation Club. Held at the Chennai amphitheatre, the event welcomed around 600 employees for an afternoon of...

While recurrence free survival is the accepted surrogate endpoint for oncology, biomarker-based outcomes assessment with ctDNA may offer greater precision and sensitivity. What could acceptance of biomarker-based surroga...

What would make you return to a former employer? After more than a decade building his career across pharma and CROs, Albert Bekfi returned to ICON as Vice President, Pharmacovigilance and Safety Reporting, Service Deli...

Winning Best Clinical Trial Supplier: Site Innovation at ABEA 2026 is a testament to the outstanding collaboration, expertise and commitment of ICON’s APAC teams. We thank IMAPAC for recognising innovation that ultimate...

Tissue‑based screening workflows create weeks‑long delays and site burden; shifting screening infrastructure toward blood‑based ctDNA assays may identify eligible patients within days while preserving analytic rigor. Exp...